SLC5A2 and hydrops fetalis: From combining nine studies, it was shown that SGLT2 inhibitors therapy substantially decreased the frequency of rehospitalization among AHF patients as a result of worsening in HF (RR = 0.71, 95% CI: 0.58–0.86, P < 0.05, I2 = 36%) (Figure 6A).